146 related articles for article (PubMed ID: 6725955)
1. Inhibition of human lymphocyte natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity by K-76 COONa, a reagent that blocks complement activity.
Hudig D; Redelman D; Minning L; Carine K
J Immunol; 1984 Jul; 133(1):408-14. PubMed ID: 6725955
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
Steele TA; Brahmi Z
J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
Nair MP; Schwartz SA
J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity.
Gersuk GM; Chang WC; Pattengale PK
J Immunol; 1988 Dec; 141(11):4031-8. PubMed ID: 2846698
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a dynamic role of the target cell membrane during the early stages of the natural killer cell lethal hit.
Deem RL; Targan SR
J Immunol; 1984 Jul; 133(1):72-7. PubMed ID: 6427347
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of cell-mediated cytotoxicity. IV. K-76 COONa, which inhibits the activity of Factor I and of C5, inhibits early events in cytotoxic T-lymphocyte-mediated cytolysis and in T-lymphocyte activation.
Redelman D; Hudig D
Cell Immunol; 1984 Oct; 88(1):16-28. PubMed ID: 6236882
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotype antibodies to the 9.1C3 blocking antibody used to probe the lethal hit stage of NK cell-mediated cytolysis.
Werkmeister JA; Burns GF; Triglia T
J Immunol; 1984 Sep; 133(3):1385-90. PubMed ID: 6611373
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
Hiserodt JC; Britvan L; Targan SR
J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352
[TBL] [Abstract][Full Text] [Related]
12. The effect of a novel C5 inhibitor (K-76 COONa) on tumor cell chemotaxis.
Bumpers HL; Baum J
J Lab Clin Med; 1983 Sep; 102(3):421-7. PubMed ID: 6886523
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of cell contact-mediated inhibition of natural killer activity.
Heiskala MK; Carpén O; Saksela E; Timonen T
J Immunol; 1987 Sep; 139(5):1414-8. PubMed ID: 3624862
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of inhibition of natural killing by a glycopeptide isolated from the K562 plasma membrane.
Targan S; Decker JM; Ades EW
Nat Immun Cell Growth Regul; 1983-1984; 3(3):113-23. PubMed ID: 6438498
[TBL] [Abstract][Full Text] [Related]
15. T cell nature and heterogeneity of recognition structures of human natural killer (NK) cells.
Fast LD; Beatty P; Hansen JA; Newman W
J Immunol; 1983 Nov; 131(5):2404-10. PubMed ID: 6415167
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human natural killer cell activity by platelet-derived growth factor.
Gersuk GM; Holloway JM; Chang WC; Pattengale PK
Nat Immun Cell Growth Regul; 1986; 5(6):283-93. PubMed ID: 3796638
[TBL] [Abstract][Full Text] [Related]
17. A novel antigenic cell surface protein associated with T200 is involved in the post-activation stage of human NK cell-mediated lysis.
Burns GF; Werkmeister JA; Triglia T
J Immunol; 1984 Sep; 133(3):1391-6. PubMed ID: 6379048
[TBL] [Abstract][Full Text] [Related]
18. Definition of a "trigger" stage in the NK cytolytic reaction sequence by a monoclonal antibody to the glycoprotein T-200.
Targan SR; Newman W
J Immunol; 1983 Sep; 131(3):1149-53. PubMed ID: 6886418
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity.
Nishiya K; Horwitz DA
J Immunol; 1982 Dec; 129(6):2519-23. PubMed ID: 7142699
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye.
Apte RS; Niederkorn JY
J Immunol; 1996 Apr; 156(8):2667-73. PubMed ID: 8609381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
